For most of the 1990s and into the 2000s, measles was largely a footnote in American public health. The country officially eliminated the disease in 2000, and for the next two decades, new cases were sporadic at best. That reality has changed sharply. Measles has been in continuous circulation across the United States for more than a year, and the numbers keep climbing.
As of early March 2026, health officials have confirmed 1,300 infections this year alone. Thirty states have reported cases in 2026, and 47 have seen infections since the start of 2025. If the current pace holds, this year will surpass 2025, which was already the worst year for measles in 35 years.
The outbreaks are no longer isolated events. A major one in Texas ran from January to August 2025. Before it was declared over, a new cluster had already ignited along the Utah and Arizona border. South Carolina followed shortly after, and that situation exploded in early 2026 and remains active today.
What is driving the measles resurgence
The answer is straightforward. Vaccination rates have fallen. Roughly 90 percent of the U.S. population has received the MMR vaccine, which guards against measles, mumps and rubella. But in some regions, coverage has dropped below 60 percent. Since around 2019 and 2020, the national rate has dipped below the 95 percent threshold required for herd immunity, and that gap is proving costly.
The virus spreads with extraordinary efficiency. One measles case can infect up to 18 others in an unvaccinated population. When pockets of unvaccinated communities exist, the disease finds them, which is precisely what has been happening across the country.
The health consequences that outlast the fever
The immediate symptoms are serious enough, but the long-term damage from measles can be far worse. People who recover can develop pneumonia or encephalitis, the latter of which can result in deafness or lasting brain damage. The virus also weakens the immune system over time, leaving survivors more vulnerable to other infections for years afterward.
In rare cases, a measles infection can trigger a fatal and progressive brain condition called subacute sclerosing panencephalitis, or SSPE, which emerges years later. A school-age child in Los Angeles recently died from this condition after being infected as an infant, before being old enough to receive the vaccine.
Three people in the U.S. died from measles in 2025, more than in any year since elimination. Of the 2,283 confirmed cases that year, roughly 11 percent required hospitalization.
The economic toll is staggering
The financial damage of recurring measles outbreaks is enormous. A 2018 to 2019 cluster in Washington state involving just 72 cases cost more than three million dollars when accounting for the public health response, medical expenses and lost productivity. Research shows that a sustained one percent drop in MMR coverage could cost the U.S. billions across health systems and the broader economy.
Why measles signals a much larger threat
Public health experts view how a country handles outbreaks as a reliable indicator of its ability to manage infectious disease more broadly. The systems needed to contain measles, including vaccination campaigns, case detection, contact tracing and isolation, are the same ones needed to fight any outbreak.
Whooping cough surged in 2024 and remained elevated in 2025. Trust in public health institutions is eroding. Polling conducted from 2023 through early 2026 found that fewer than half of Americans trust the government to provide reliable vaccine information.
The fractures that measles is exposing in America’s public health infrastructure could leave the country dangerously unprepared for whatever threat comes next. Building that trust back up and restoring vaccination rates to safe levels will take sustained effort, political will and a public that believes the science. Right now, none of those things are guaranteed.
